Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by OracleOfOntarioon Sep 03, 2017 12:07pm
311 Views
Post# 26651902

Loblaws already providing training in anticipation for sales

Loblaws already providing training in anticipation for salesLoblaw CEO Galen G. Weston says company is watching marijuana legislation By Linda Nguyen, The Canadian Press September 3, 2017 9:43 AM TORONTO The CEO and chairman of Loblaw Companies says he hasn't ruled out the possibility of selling recreational marijuana, a slight shift in position for Canada's largest grocery and drugstore chain. Galen G. Weston said his focus remains on dispensing medical cannabis. But when asked whether Loblaw has closed the book on entering the recreational marijuana market, Weston said, "You can never predict the future," adding that the company is closely watching for more details about the federal government's proposed legalization of the drug. "It's fair to say that at this point, based on everything we know today, medical is a place where we see an opportunity," Weston said at Loblaw's annual general meeting. "We believe there is a strong and growing medical case for marijuana and pharmacies should be an important distribution system for medical marijuana." At last year's annual general meeting, Weston said Loblaw (TSX:L) was only interested in being an active player in the medical use of cannabis. Last October, Shoppers Drug Mart, which is owned by Loblaw, applied for a Health Canada licence to dispense medical marijuana. The company says it is still waiting for a response, but it has already provided training to its pharmacists on dispensing the drug at more than 1,800 Shoppers and Loblaw locations. Ottawa introduced a suite of bills last month to legalize marijuana by July 2018. Weston said the company would distribute medical marijuana products that don't require patients to smoke.
Bullboard Posts